BIO-key International (BKYI) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue increased 18% year-over-year to $2.14 million, driven by expanded software deployments, higher license and hardware sales, and large customer expansions.

• High-margin license revenue rose 52% to $1.44 million, reflecting a shift toward more profitable business lines and expanded deployments from long-term customers.

• Net loss narrowed to $739,000 in Q3 2024 from $1.84 million in Q3 2023, with improved gross margin and stable operating expenses.

• Cash position improved to $1.8 million at September 30, 2024, up from $0.5 million at year-end 2023, aided by $1.9 million in warrant financing.

• Significant new and follow-on orders were secured post-quarter, including a $910,000 order from a financial services client and a $500,000 follow-on from an international defense ministry.

Financial highlights

• Q3 2024 revenue: $2.14 million (up from $1.8 million in Q3 2023 and $1.1 million in Q2 2024), with license fees up 52% and hardware sales up 56%, offset by a 55% decline in services.

• Gross profit improved to $1.7 million (78.3% margin) from $0.3 million (18.7%) in Q3 2023, reflecting higher-margin license and hardware sales and lower cost of goods sold.

• Net loss per share improved to $0.39 in Q3 2024 from $3.22 in Q3 2023; nine-month net loss reduced to $2.9 million from $6.1 million year-over-year.

• Operating expenses decreased 9% year-over-year, with reductions in admin, sales, and marketing, partially offset by higher R&D.

• Cash and cash equivalents were $1.8 million at September 30, 2024, up from $511,000 at year-end 2023.

Outlook and guidance

• 2024 revenue is expected to meet or exceed 2023’s $7.75 million, implying at least $2.3 million in Q4 revenue, primarily from license sales.

• Q4 revenue to include a portion of a $910,000 order from a financial services customer, with the remainder recognized in Q1 2025.

• Management targets positive operating cash flow and profitability in coming quarters, with ongoing cost control and strategic opportunities.

• Service revenue is expected to remain at current lower levels due to the loss of a major customer.

• Additional financing will likely be required within the next twelve months to support operations and regain Nasdaq compliance.